KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Construction in Progress (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Construction in Progress for 17 consecutive years, with $2.6 billion as the latest value for Q4 2025.

  • Quarterly Construction in Progress rose 3.18% to $2.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 billion through Dec 2025, up 3.18% year-over-year, with the annual reading at $2.6 billion for FY2025, 3.18% up from the prior year.
  • Construction in Progress hit $2.6 billion in Q4 2025 for Abbott Laboratories, up from $2.5 billion in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $2.6 billion in Q4 2025 to a low of $1.3 billion in Q4 2021.
  • Historically, Construction in Progress has averaged $2.0 billion across 5 years, with a median of $2.1 billion in 2023.
  • Biggest five-year swings in Construction in Progress: fell 3.91% in 2021 and later surged 39.08% in 2023.
  • Year by year, Construction in Progress stood at $1.3 billion in 2021, then rose by 13.8% to $1.5 billion in 2022, then soared by 39.08% to $2.1 billion in 2023, then grew by 20.54% to $2.5 billion in 2024, then grew by 3.18% to $2.6 billion in 2025.
  • Business Quant data shows Construction in Progress for ABT at $2.6 billion in Q4 2025, $2.5 billion in Q4 2024, and $2.1 billion in Q4 2023.